Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Cancer

Explore clinical trials studying Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

242 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Cancer trial results

Completed

A Study for Participants With Small-Cell Lung Cancer

NCT01025284

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Torrington, Connecticut, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Athens, Georgia, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Marietta, Georgia, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Scarborough, Maine, United States
View Trial Details
Completed

Study of Anlotinib in Patients With Small Cell Lung Cancer (ALTER1202)

NCT03059797

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • The 307th Hospital of Chinese People's Liberation Army Beijing, Beijing Municipality, China
  • Guangdong General Hospital Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
View Trial Details
Completed

A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer

NCT01497873

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Chungbuk University Hospital Daegu, South Korea
  • Keimyung University Dongsan Center Daegu, South Korea
  • National Cancer Center Goyang, South Korea
  • Asan Medical Center Seoul, South Korea
View all 14 locations
View Trial Details
Completed

Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC)

NCT02038647

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Los Angeles, California, United States
  • Sacramento, California, United States
  • New Haven, Connecticut, United States
  • Washington D.C., District of Columbia, United States
View all 61 locations
View Trial Details

Related conditions